Paying user area
Try for free
Allergan Inc. pages available for free this week:
- Balance Sheet: Assets
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Solvency Ratios
- Analysis of Long-term (Investment) Activity Ratios
- Common Stock Valuation Ratios
- Enterprise Value to FCFF (EV/FCFF)
- Price to FCFE (P/FCFE)
- Dividend Discount Model (DDM)
- Analysis of Revenues
- Analysis of Debt
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Allergan Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Current Enterprise Value (EV)
Current share price (P) | |
No. shares of common stock outstanding | |
US$ in thousands | |
Common equity (market value)1 | |
Add: Preferred stock, $.01 par value; none issued (per books) | |
Add: Noncontrolling interest (per books) | |
Total equity | |
Add: Notes payable (per books) | |
Add: Convertible notes (per books) | |
Add: Long-term debt, excluding current maturities (per books) | |
Total equity and debt | |
Less: Cash and equivalents | |
Less: Short-term investments | |
Enterprise value (EV) |
Based on: 10-K (reporting date: 2014-12-31).
1 Common equity (market value) = Share price × No. shares of common stock outstanding
= ×
Historical Enterprise Value (EV)
Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).
1 Data adjusted for splits and stock dividends.
2 Closing price as at the filing date of Allergan Inc. Annual Report.
3 2014 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= ×
Item | Description | The company |
---|---|---|
EV | Enterprise value is total company value (the market value of common equity, debt, and preferred equity) minus the value of cash and short-term investments. | Allergan Inc. EV increased from 2012 to 2013 and from 2013 to 2014. |